Analysts Expect Tyme Technologies Inc (TYME) to Post -$0.08 Earnings Per Share

Analysts predict that Tyme Technologies Inc (NASDAQ:TYME) will report earnings per share of ($0.08) for the current quarter, Zacks reports. Zero analysts have made estimates for Tyme Technologies’ earnings. Tyme Technologies posted earnings of ($0.06) per share in the same quarter last year, which would suggest a negative year over year growth rate of 33.3%. The business is expected to issue its next quarterly earnings results on Wednesday, February 6th.

On average, analysts expect that Tyme Technologies will report full year earnings of ($0.30) per share for the current fiscal year. For the next fiscal year, analysts forecast that the firm will post earnings of ($0.37) per share. Zacks Investment Research’s EPS averages are an average based on a survey of sell-side analysts that that provide coverage for Tyme Technologies.

A number of research firms recently commented on TYME. BidaskClub upgraded shares of Tyme Technologies from a “strong sell” rating to a “sell” rating in a research note on Wednesday, November 28th. HC Wainwright reiterated a “buy” rating and issued a $10.00 target price on shares of Tyme Technologies in a research note on Wednesday, November 7th. Finally, Zacks Investment Research cut shares of Tyme Technologies from a “buy” rating to a “hold” rating in a research note on Friday, October 12th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and two have issued a buy rating to the company. The stock has an average rating of “Hold” and a consensus price target of $7.58.

Hedge funds and other institutional investors have recently made changes to their positions in the business. Renaissance Technologies LLC acquired a new stake in Tyme Technologies during the 3rd quarter valued at approximately $100,000. Rhumbline Advisers acquired a new stake in Tyme Technologies during the 2nd quarter valued at approximately $110,000. Schwab Charles Investment Management Inc. acquired a new stake in Tyme Technologies during the 2nd quarter valued at approximately $248,000. Bank of New York Mellon Corp acquired a new stake in Tyme Technologies during the 2nd quarter valued at approximately $267,000. Finally, Perkins Capital Management Inc. lifted its stake in Tyme Technologies by 330.0% during the 2nd quarter. Perkins Capital Management Inc. now owns 101,050 shares of the company’s stock valued at $319,000 after acquiring an additional 77,550 shares during the period. Institutional investors and hedge funds own 11.28% of the company’s stock.

TYME stock traded up $0.21 during trading on Monday, reaching $4.13. The company had a trading volume of 2,533,100 shares, compared to its average volume of 322,131. The stock has a market capitalization of $403.79 million, a PE ratio of -19.67 and a beta of 0.75. Tyme Technologies has a twelve month low of $1.93 and a twelve month high of $8.30.

Tyme Technologies Company Profile

Tyme Technologies, Inc, a clinical-stage biotechnology company, develops novel cancer therapeutics. It is developing SM-88, a combination therapy based on dysfunctional metyrosine derivatives in Phase II development for metastatic pancreatic cancer and biomarker-recurrent prostate cancer. The company was founded in 2011 and is headquartered in New York, New York.

See Also: Compound Interest and Why It Matters When Investing

Get a free copy of the Zacks research report on Tyme Technologies (TYME)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Tyme Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tyme Technologies and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit